YOLANDA CRAWFORD: Open Payments
NPI 1801179312 · DELAWARE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,248 in 71 payments from 22 companies in 2025. Trend: 2023 $1,089 · 2024 $957 · 2025 $1,248
Food & beverage: $1,191Speaker / faculty: $57
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $238 |
| AstraZeneca Pharmaceuticals LP | 12 | $213 |
| Novo Nordisk Inc | 12 | $191 |
| PFIZER INC. | 5 | $84 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Exact Sciences Corporation | 2 | $53 |
| Gilead Sciences, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
Products named: AIRSUPRA, UBRELVY, FARXIGA, Rybelsus, Wegovy, Veozah, CAPLYTA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
